Compare Roivant Sciences Ltd. Common Shares (ROIV) vs UBS Group AG Registered Ordinary Shares (UBS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Roivant Sciences Ltd. Common Shares vs UBS Group AG Registered Ordinary Shares — how do they compare? Roivant Sciences Ltd. Common Shares trades at $34.21 (market cap $25.09B), while UBS Group AG Registered Ordinary Shares trades at $47.69 (market cap $144.63B). The key difference: UBS Group AG Registered Ordinary Shares is far larger — about 5.8× Roivant Sciences Ltd. Common Shares's market cap, and UBS Group AG Registered Ordinary Shares pays a 2.32% dividend while Roivant Sciences Ltd. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Roivant Sciences Ltd. Common Shares for 0 Days and UBS Group AG Registered Ordinary Shares for 0 Days on average.
| ROIV | UBS | |
|---|---|---|
Market Cap | $25.09B | $144.63B |
Volume | 5,738,571 | 1,746,723 |
Sector | Health | Financials |
52-Week High | $41.81 | $55.72 |
52-Week Low | $16.04 | $36.41 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $21.36B | $311.50B |
Dividend Yield | — | 2.32% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Roivant Sciences Ltd. Common Shares
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →About UBS Group AG Registered Ordinary Shares
UBS is a global financial services company focused on wealth management, investment banking, and asset management. It serves private, corporate, and institutional clients.
Read more on UBS →
